Total Payments
$6,359
2024 Payments
$889.95
Companies
18
Transactions
170
Medicare Patients
8,430
Medicare Billing
$393,394
Payment Breakdown by Category
Food & Beverage$3,597 (56.6%)
Travel$2,522 (39.7%)
Education$240.00 (3.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,597 | 159 | 56.6% |
| Travel and Lodging | $2,522 | 9 | 39.7% |
| Education | $240.00 | 2 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,127 | 56 | $0 (2024) |
| Terumo Medical Corporation | $1,291 | 12 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $383.07 | 20 | $0 (2024) |
| PFIZER INC. | $284.08 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $248.73 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $218.95 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $179.77 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $155.14 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $145.02 | 8 | $0 (2024) |
| ShockWave Medical, Inc | $112.89 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $889.95 | 35 | Abbott Laboratories ($385.13) |
| 2023 | $771.69 | 34 | Abbott Laboratories ($333.65) |
| 2022 | $800.49 | 32 | Abbott Laboratories ($440.11) |
| 2021 | $2,357 | 45 | Abbott Laboratories ($1,968) |
| 2020 | $37.68 | 3 | Janssen Pharmaceuticals, Inc ($25.41) |
| 2019 | $86.38 | 5 | Regeneron Healthcare Solutions, Inc. ($31.47) |
| 2018 | $1,373 | 13 | Terumo Medical Corporation ($1,280) |
| 2017 | $42.65 | 3 | Amgen Inc. ($28.61) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.70 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/07/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Vascular | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $142.63 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/13/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/10/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Vascular | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Cardiovascular | ||||||
| 08/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/22/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: Cardiovascular | ||||||
| 06/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiology | ||||||
| 05/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Vascular | ||||||
| 05/09/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Vascular | ||||||
| 05/01/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: Cardiovascular | ||||||
| 04/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,041 | 2,929 | $448,780 | $95,279 |
| 2022 | 25 | 2,075 | 2,702 | $542,024 | $92,822 |
| 2021 | 28 | 2,104 | 2,604 | $575,178 | $99,649 |
| 2020 | 29 | 2,210 | 2,766 | $744,924 | $105,643 |
Total Patients
8,430
Total Services
11,001
Medicare Billing
$393,394
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 257 | $71,327 | $22,703 | 31.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 444 | 460 | $120,596 | $21,468 | 17.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 74 | 75 | $43,121 | $9,969 | 23.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,024 | 1,661 | $50,744 | $8,969 | 17.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 37 | 39 | $39,633 | $7,392 | 18.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 12 | 14 | $28,310 | $5,884 | 20.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 54 | $17,478 | $4,999 | 28.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $16,706 | $3,023 | 18.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $10,572 | $2,125 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $8,135 | $1,758 | 21.6% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 16 | 17 | $9,055 | $1,413 | 15.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 34 | 67 | $6,364 | $1,128 | 17.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 15 | $3,318 | $922.95 | 27.8% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 11 | 12 | $4,047 | $857.16 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $3,332 | $835.44 | 25.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 58 | 62 | $9,821 | $583.16 | 5.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 12 | 12 | $1,415 | $387.52 | 27.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 16 | 18 | $1,663 | $270.90 | 16.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 27 | $1,641 | $254.61 | 15.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 57 | $805.00 | $239.40 | 29.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 13 | 13 | $697.00 | $97.92 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 212 | $53,428 | $18,693 | 35.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 371 | 382 | $108,964 | $18,028 | 16.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 50 | 50 | $60,982 | $9,762 | 16.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,026 | 1,488 | $82,274 | $8,938 | 10.9% |
About Dr. Fernando De La Serna, MD
Dr. Fernando De La Serna, MD is a Cardiovascular Disease healthcare provider based in Morganton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093923187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernando De La Serna, MD has received a total of $6,359 in payments from pharmaceutical and medical device companies, with $889.95 received in 2024. These payments were reported across 170 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,597).
As a Medicare-enrolled provider, De La Serna has provided services to 8,430 Medicare beneficiaries, totaling 11,001 services with total Medicare billing of $393,394. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Morganton, NC
- Active Since 05/20/2007
- Last Updated 04/13/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1093923187
Products in Payments
- Assurity Pacemaker (Device) $1,789
- Navicross (Device) $1,265
- JOT DX (Device) $552.77
- ELIQUIS (Drug) $354.82
- VERQUVO (Drug) $248.73
- XARELTO (Drug) $218.95
- AVEIR (Device) $198.84
- ENTRESTO (Drug) $197.72
- LEQVIO (Drug) $185.35
- CONFIRM RX (Device) $161.85
- JARDIANCE (Drug) $145.02
- DRAGONFLY OPSTAR (Device) $134.17
- FARXIGA (Drug) $110.67
- CAMZYOS (Drug) $109.03
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $89.07
- Xience Sierra Coronary Stent (Device) $73.66
- OPTIS (Device) $67.82
- Xience Sierra Coronary Stent System (Device) $54.82
- Repatha (Biological) $50.41
- COREVALVE EVOLUT R (Device) $35.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Morganton
Sean Pokorney, Md, MD
Cardiovascular Disease — Payments: $410,394
Cardiovascular Disease $410,394
Dr. Steven Isserman, M.d, M.D
Cardiovascular Disease — Payments: $8,645
Cardiovascular Disease $8,645
Dr. Walter Pearcy, M.d, M.D
Cardiovascular Disease — Payments: $4,663
Cardiovascular Disease $4,663
Dr. Ryan Miller, M.d, M.D
Cardiovascular Disease — Payments: $1,216
Cardiovascular Disease $1,216
Dr. Sardar Shah Khan, M.d., M.r.c.p, M.D., M.R.C.P
Cardiovascular Disease — Payments: $198.26
Cardiovascular Disease $198.26
Dr. Charles Vasey, M.d, M.D
Cardiovascular Disease — Payments: $43.51
Cardiovascular Disease $43.51